With a larger study group and longer follow-up time, we could have conducted more sophisticated analyses specifically aimed at identifying BCR/TCR differences among patients with B-ALL who exhibit diverse clinical characteristics. This evidence concerns the gene BCR and precursor B-cell acute lymphoblastic leukemia.